Stem Cell-Based Toxicity Screening

  title={Stem Cell-Based Toxicity Screening},
  author={S. Greenhough and D. Hay},
  journal={Pharmaceutical Medicine},
  • S. Greenhough, D. Hay
  • Published 2012
  • Biology
  • Pharmaceutical Medicine
  • Preclinical cell-based toxicity screening is an essential stage in the drug development process. Current technology is based on immortalized cell lines, rodent cells and primary human hepatocytes, all of which suffer from shortcomings. Cell lines and rodent cells have limited relevance to human physiology, while primary human cells remain a scarce and variable resource. These systems are inadequate, as evidenced by the high levels of compound attrition in the clinical trial and postmarketing… CONTINUE READING
    Hepatic cells and enzymes reactions in wistar rats exposed to x-ray film processing chemicals
    • 1
    • PDF


    Publications referenced by this paper.
    Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells
    • 911
    Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.
    • 442
    Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.
    • 509
    • PDF
    Disease-Specific Induced Pluripotent Stem Cells
    • 1,967
    • PDF
    Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
    • 670
    • PDF
    Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells
    • 371
    Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
    • 11,330
    • PDF